Kalaris (KLRS) PT Lowered to $25 at Citizens Ahead of Phase 1b/2 MAD data in 2027
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Kalaris (NASDAQ: KLRS) to $25.00 (from $26.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
